3 reasons why the Cineworld share price rallied 16% last week

The anticipation of results, along with positive vaccine news, are some reasons that the Cineworld share price is rising, says Jonathan Smith.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

Hand arranging wood block stacking as step stair on paper pink background

Image source: Getty Images

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

In terms of companies that have been hit hard by the pandemic, Cineworld (LSE:CINE) definitely ranks highly. The UK’s largest cinema operator has 127 sites here, as well as hundreds of others in the US. Due to lockdowns, cancelled movie releases and very limited demand for consumers to enter a confined space surrounded by strangers, the business has really struggled. Technically, the Cineworld share price is up 121% over the past year, but this time period cuts off the stock market crash from earlier in March 2020.

Upcoming results

Pulling the time frame out to two years gives a better indication on the state of the company. The Cineworld share price is down almost 50% over two years. If I now pull in the time frame to one week, it shows me that the shares rose an impressive 16%. From this I gather that the long-term past performance hasn’t been great, but it seems to be improving in the short term.

One reason for this is the anticipation of full-year results. These are due out this week, with an expectation of posting a pre-tax loss around £500m. So why is the Cineworld share price rallying? I think it’s a similar story to what we saw with Rolls-Royce shares recently. Despite posting a loss of £2.9bn, the shares rallied simply because investors were prepared for the bad news. The loss was discounted, and the outlook was positive for 2021, so people bought the shares.

I think this is the same case for Cineworld. I already know a large loss is coming, so that won’t surprise me. It’s actually more likely that there will be something positive to take from the report, such as higher liquidity or new plans to bounce back. It seems I’m not alone in my thinking, and investors are buying Cineworld shares in anticipation of this.

Cineworld shares pushed higher by vaccine news

Another reason the Cineworld share price rallied last week was due to positive news concerning the vaccination initiatives in both the UK and US. Here in the UK, over half the adult population has been vaccinated. In the US, the vaccination figure hit 100m last Friday. Both are positive statistics that support the reopening of cinemas.

In the UK, cinemas are expected to reopen in the middle of May. Cineworld secured over £500m of funding late last year that will keep it running until May. So the vaccine numbers coming out from the Government are helping to push the Cineworld share price higher. It looks like the business may be able to survive.

Yet despite this short-term boost, I still see plenty of risks to the Cineworld share price being able to continue such a rally. I don’t have time to run through them all, but one key issue is the rise of competitors such as Netflix. We’ve got the Oscars coming up, and incredibly Netflix has a record 35 nominations! So traditional cinemas could quickly become irrelevant as streaming platforms (turned studios) take over.

Also, even with a bounce-back, it may take some time for cinema attendance to reach 2019 levels. And let’s not forget the heavy debt load the company has.

From my point of view, I won’t be buying Cineworld shares any time soon, even with the move higher recently.

RISK WARNING: should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice. The Motley Fool believes in building wealth through long-term investing and so we do not promote or encourage high-risk activities including day trading, CFDs, spread betting, cryptocurrencies, and forex. Where we promote an affiliate partner’s brokerage products, these are focused on the trading of readily releasable securities.

jonathansmith1 has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended Netflix. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Publish Test

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut…

Read more »

Investing Articles

JP P-Press Update Test

Read more »

Investing Articles

JP Test as Author

Test content.

Read more »

Investing Articles

KM Test Post 2

Read more »

Investing Articles

JP Test PP Status

Test content. Test headline

Read more »

Investing Articles

KM Test Post

This is my content.

Read more »

Investing Articles

JP Tag Test

Read more »

Investing Articles

Testing testing one two three

Sample paragraph here, testing, test duplicate

Read more »